BIOMAT Database Logo BIOMAT Database Logo

Pseudotumor cerebri associated with danazol withdrawal. 1991

M Fanous, and L M Hamed, and C E Margo

UI MeSH Term Description Entries
D011559 Pseudotumor Cerebri A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS). Benign Intracranial Hypertension,Idiopathic Intracranial Hypertension,Intracranial Hypertension, Benign,Intracranial Hypertension, Idiopathic,Hypertension, Benign Intracranial,Hypertension, Idiopathic Intracranial
D003613 Danazol A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

M Fanous, and L M Hamed, and C E Margo
[Pseudotumor cerebri induced by danazol].
January 1990, Bulletin de la Societe belge d'ophtalmologie,
M Fanous, and L M Hamed, and C E Margo
Pseudotumor cerebri induced by danazol.
February 1989, American journal of ophthalmology,
M Fanous, and L M Hamed, and C E Margo
Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease.
March 1994, American journal of ophthalmology,
M Fanous, and L M Hamed, and C E Margo
Quetiapine-Associated Pseudotumor Cerebri.
January 2020, American journal of therapeutics,
M Fanous, and L M Hamed, and C E Margo
Pseudotumor cerebri associated with pernicious anemia.
April 1969, Annals of internal medicine,
M Fanous, and L M Hamed, and C E Margo
Pseudotumor cerebri associated with obstructive nephropathy.
January 1986, Pediatric neurology,
M Fanous, and L M Hamed, and C E Margo
Pseudotumor cerebri associated with Sjögren's syndrome.
April 2003, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
M Fanous, and L M Hamed, and C E Margo
Pseudotumor cerebri associated with kawasaki disease.
October 1997, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
M Fanous, and L M Hamed, and C E Margo
Pseudotumor cerebri associated with cyclosporine use.
September 1996, American journal of ophthalmology,
M Fanous, and L M Hamed, and C E Margo
Pseudotumor cerebri associated with nalidixic acid.
August 1974, Urology,
Copied contents to your clipboard!